Apr 04, 2025 8:00am EDT OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program
Mar 17, 2025 8:00am EDT OPKO Health and Entera Bio Enter into Collaboration Agreement to Advance Oral GLP-1/Glucagon Tablet Candidate into the Clinic to Treat Obesity and Metabolic Disorders
Mar 11, 2025 9:00am EDT Labcorp Announces Acquisition of Select Assets of BioReference Health’s Innovative Oncology and Related Clinical Testing Services Businesses
Feb 27, 2025 4:10pm EST OPKO Health Reports Fourth Quarter 2024 Business Highlights and Financial Results
Feb 13, 2025 4:05pm EST OPKO Health to Report Fourth Quarter 2024 Financial Results on February 27, 2025
Jan 07, 2025 8:00am EST OPKO Health’s ModeX Therapeutics Announces Epstein-Barr Virus Vaccine Candidate Enters Phase I Clinical Study in Collaboration with Merck
Nov 20, 2024 8:00am EST OPKO Health to Participate in the Piper Sandler 36th Annual Healthcare Conference
Nov 07, 2024 4:05pm EST OPKO Health Reports Third Quarter 2024 Business Highlights and Financial Results